Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- EUROPEAN JOURNAL OF CANCER140 · pp.19 · 2020
- 피인용
- Web of Science 23Scopus 30
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 7.275
- ISSN
- 0959-8049
저자
- Lee, Young-Sun제1저자Department of Internal medicine, Korea University College of Medicine, Seoul, South korea
- Jung, Young K.Department of Internal medicine, Korea University College of Medicine, Seoul, South korea
- Kim, Ji H.교신저자Department of Internal medicine, Korea University College of Medicine, Seoul, South korea
- Cho, Sung B.교신저자Department of internal medicine, Chonnam National University Medical School
- Kim, Do Y.Yonsei Liver Center, Severance Hospital, Seoul, Korea
- Kim, Moon Y.Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju Severance Christan Hospital
- Kim, Hyung J.Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea
- Seo, Yeon S.Department of Internal medicine, Korea University College of Medicine, Seoul, South korea
- 윤기태Department of internal medicine, Pusan National University school of Medicine, Pusan National University Yangsan Hospital
- 홍영미Department of internal medicine, Pusan National University school of Medicine, Pusan National University Yangsan Hospital
- Lee, Jeong-HoonDepartment of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine
- Lee, Hyun W.Department of Internal Medicine, Yonsei University College of Medicine
- Yim, Hyung J.Department of Internal medicine, Korea University College of Medicine, Seoul, South korea
- Jang, Byoung K.Department of Internal Medicine, Keimyung University School of Medicine
- Jang, Eun S.Department of Intetnal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi
- Jang, Jae Y.Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, Republic of Korea
- Hwang, Sang Y.Department of Internal Medicine, Dongnam Institute of Radiological & Medical Sciences
초록
Background: Hand-foot skin reaction (HFSR) is the most common adverse event during sorafenib treatment in patients with hepatocellular carcinoma (HCC). In the present study, we aimed to investigate the role of urea cream in the prevention of HFSR or amelioration of HFSR severity. Patients and methods: Patients with HCC were treated with either placebo cream or urea cream for 12 weeks concomitantly with sorafenib treatment. HFSR development, the Hand-Foot Skin Reaction and Quality of Life (HF-QoL) questionnaire score, and adverse events were assessed at 2, 4, 8 and 12 weeks. Results: Of the 288 patients, 247 patients, with 117 patients in the placebo control group and 130 patients in the urea cream group, were analysed. The urea cream group showed a trend towards a lower cumulative incidence of any-grade HFSR (log-rank, P = 0.247) and severe HFSR of grade II or higher (log-rank, P = 0.394) without statistical significance. In the incidence by time point, the incidence of severe HFSR of grade II or higher was significantly lower in the urea cream group than in the placebo control group at 2 weeks (13.8% versus 23.9%, P = 0.042). The urea cream group showed a significantly better HF-QoL questionnaire score than the placebo control group (11.8 versus 19.7, P = 0.014) at 12 weeks. Conclusions: Treatment with urea cream showed a lower incidence of severe sorafenib-induced HFSR at 2 weeks and reduced the tendency of HFSR development in HCC patients. Therefore, treatment with urea cream may be considered for prophylaxis or improvement of HFSR grade in HCC patients treated with sorafenib. (C) 2020 Elsevier Ltd. All rights reserved.
키워드
HepatocellularcarcinomaHand-foot skin reactionUrea creamOF-LIFE QUESTIONNAIREPHASE-IIITHERAPYHand–foot skin reactionHepatocellular carcinoma
식별자
- Scopus EID
- 2-s2.0-85092173342
- WoS UID
- 000588150600003



로그인
연구물 목록으로